• Dendreon Opens It First Clinical Trial in the European Union

    Updated: 2012-09-30 06:51:42
    On September 27th Dendreon announced that it has enrolled and started its first patient with metastatic advanced prostate cancer that is castrate resistanr in a European Union based clinical trial of Provenge. Finally, men in the EU can hope that in the near future that Provenge could become available to them. The trial is hoped [...]

  • New Melanoma Treatment Might Delay Cancer Progression

    Updated: 2012-09-29 16:30:44
    Health News New Melanoma Treatment Might Delay Cancer Progression Print E-mail SATURDAY , Sept . 29 HealthDay News Researchers say they've discovered a two-drug combination that delays treatment resistance in patients with advanced . melanoma By targeting different points in the same growth-factor pathway , the kinase inhibitor drugs dabrafenib and trametinib postponed the development of drug resistance in patients with BRAF-positive metastatic melanoma , the study authors . said Melanoma is the most serious , and often deadly , form of skin cancer . In about half of patients with melanoma that has spread , tumor growth is caused by genetic mutations that keep the BRAF protein part of the MAPK cell growth pathway constantly activated . Drugs that inhibit BRAF activity can rapidly stop and

  • Breast Cancer Drug Linked to Sexual Problems in Older Women

    Updated: 2012-09-29 00:07:57
    Health News Breast Cancer Drug Linked to Sexual Problems in Older Women Print E-mail FRIDAY , Sept . 28 HealthDay News Postmenopausal women treated for breast cancer with drugs known as aromatase inhibitors have high rates of sexual problems , which is an important and underestimated issue , according to a new study from . Sweden Nearly three-quarters of these women reported insufficient lubrication , 56 percent had pain during intercourse , half said their sexual interest was low , and 42 percent were dissatisfied with their sex . life These percentages are much higher than for postmenopausal women who weren't treated for beast cancer , according to researchers Dr . Juliane Baumgart and colleagues at Orebro University and Uppsala . University The study was published online this month in

  • Quick Survey May Pick Up Ovarian Cancer Warnings Study

    Updated: 2012-09-29 00:07:57
    : Health News Quick Survey May Pick Up Ovarian Cancer Warnings : Study Print E-mail FRIDAY , Sept . 28 HealthDay News A simple three-question survey might identify women who have symptoms that may indicate ovarian cancer , according to a new . study The two-minute paper-and-pencil questionnaire can be given in a doctor's office and checks for six warning signs that may improve early detection of ovarian cancer , according to researchers at the Fred Hutchinson Cancer Research Center in . Seattle The survey asks women if they are experiencing one or more of the following symptoms : abdominal and or pelvic pain feeling full quickly and or unable to eat normally abdominal bloating and or increased abdomen size . It also asks about the frequency and duration of these . symptoms The study

  • A Common Advanced Prostate Cancer Emergency – Spinal Cord Compression

    Updated: 2012-09-28 18:53:26
    Spinal cord compression is not an uncommon occurrence in men with advanced prostate cancer. Bones are the most common target of advanced prostate cancer, including the spine. Sadly, there is often a delay in diagnosing spinal cord compression resulting from prostate cancer. These delays in diagnosis can influence the eventual functional outcome. Oncologists, primary care [...]

  • Researchers show Myc protein is cancer's 'volume control'

    Updated: 2012-09-28 17:27:00
    A protein called Myc, commonly found at high levels inside cancer cells, fuels the disease by allowing cells to override their in-built self-destruct mechanisms, US scientists have discovered.

  • Genes May Influence Impotence After Prostate Radiation

    Updated: 2012-09-28 06:20:33
    Health News Genes May Influence Impotence After Prostate Radiation Print E-mail THURSDAY , Sept . 27 HealthDay News Men with certain gene mutations may be at higher risk for erectile dysfunction after receiving radiation therapy for prostate cancer than other patients , a new study suggests . Although far from clinical use now , genetic analysis may someday play a role in personalizing treatment for prostate cancer patients , researchers . said We believe there are genetic factors that make patients more likely to develop complications from treatment , said lead researcher Barry Rosenstein , from the department of radiation oncology at Mount Sinai School of Medicine in New York City . Erectile dysfunction , or impotence , is a common side effect of radiation therapy , he said . Urinary

  • New trial will investigate cancer-fighting properties of chemical related to cannabis

    Updated: 2012-09-28 00:01:00
    Chemicals similar to those found in cannabis form the basis of a new drug that is being trialled in UK cancer patients for the first time by researchers at the Cancer Research UK and National Institute for Health Research (NIHR) Experimental Cancer Medicine Centre in Newcastle.

  • September is Prostate Cancer Awareness Month

    Updated: 2012-09-27 19:57:00
    About Us Sponsored : by CTCA Cancer News Cancer Survivors Prefer to Stay With Cancer Doctors : Study Findings highlight need for coordinated care for their unique health needs Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests Cancer Nutrition Diet Recipes

  • DNA Patterns May Predict ED After Radiation

    Updated: 2012-09-27 16:00:00
    A suite of 12 genetic variations may help doctors determine who will have erectile dysfunction after radiation therapy for prostate cancer, researchers reported.

  • Prostate MRI May Help Decide on Watchful Waiting

    Updated: 2012-09-26 18:30:00
    MRI evaluation of clinically low-risk prostate cancer demonstrated high accuracy for predicting disease status in men evaluated for watchful waiting, data from a prospective clinical study showed.

  • Soaring mouth cancer rates highlight need for greater dentists' awareness

    Updated: 2012-09-26 00:01:00
    Rising rates of mouth cancer mean that it's more important than ever that dentists and members of the dental team can promote prevention, detect warning signs and refer patients appropriately.

  • How To Dispose of Unneeded Medications

    Updated: 2012-09-25 17:23:49
    We all manage to accumulate prescription and non-prescription medications that we no longer need. They can sit in our medicine chests accumulating dust or even be stolen and sold for illegal use. Some people just throw them away in their garbage cans and others flush them down the toilet. Al three of these solutions are [...]

  • Cancer death rates set to drop 17 per cent by 2030

    Updated: 2012-09-25 00:01:00
    The rates of people dying from cancer are predicted to fall by 17 per cent (16.8) in the UK by 2030 according to new statistics released today by Cancer Research UK (Tuesday).

  • Gene variant linked to male breast cancer

    Updated: 2012-09-24 17:45:00
    An inherited gene variant that increases a man's chance of developing breast cancer by up to 50 per cent has been identified by an international team of scientists.

  • Study gives better picture of genetic causes of breast cancer

    Updated: 2012-09-23 18:00:00
    Research from the US has given scientists a better understanding of the genetic and molecular defects inside breast cancer cells.

  • Coming in Early 2013 – A Genetic Test to Predict Which Prostate Cancers Need treatment and Which can be Subject to Active Surveillance

    Updated: 2012-09-23 02:35:27
    Genomic Health, Inc. has announced they have had positive results from a large clinical validation study of a biopsy-based prostate cancer test designed to predict adverse pathology in men with early prostate cancer. The study, performed in collaboration with prostate cancer researchers at the University of California, San Francisco (UCSF), met its primary endpoint by [...]

  • Can Tamoxifen Manage Breast Events Induced by Non-Steroidal Antiandrogens in Men with Advanced Prostate Cancer?

    Updated: 2012-09-21 20:18:54
    Many of us who are fighting advanced prostate cancer struggle with the perplexing side effects of non-steroidal antiandrogens (like Casodex). These side effects include gynecomastia (breast enlargement) and breast pain. In most cases as we use these drugs our breasts grow, become very sensitive and/or painful. In my case my breasts have grown to the [...]

  • Nearly one in three cancers in elderly are diagnosed as emergency admission to hospital

    Updated: 2012-09-21 00:01:00
    Almost a third (31 per cent) of cancers in the over 70s – around 38,300 a year in England – are diagnosed through emergency admission to hospital, according to new research by the National Cancer Intelligence Network (NCIN), published today (Friday) in the British Journal of Cancer (BJC).

  • Sharecare Honors Ten Prostate Cancer Influencers, Including Me!

    Updated: 2012-09-20 22:17:26
    Yesterday, I was given the honor of being named as one of the ten “influencers” in prostate cancer. The honor was extended by sharecare.org (twitter- Sharecare ?@SharecareNow ). Sharecare is active in many health issues, their prostate cancer expert’s page can be seen at: http://sharecare.to/Ql937V I am joined by some remarkable people; John McHugh, M.D. [...]

  • Survival Advantage of Abiraterone Acetate (Zytiga) in Men with Castrate Resistant Metastatic Advanced Prostate Cancer

    Updated: 2012-09-19 19:30:56
    We all know that abiraterone acetate (Zytiga) plus prednisone provides a survival advantage for men with castrate resistant advanced prostate cancer (mCRPC) who have had prior treatment with a taxane based chemotherapy. New information has shown that abiraterone acetate offers a somewhat longer overall survival benefit than the data originally presented when the trial halted [...]

  • PCAP Makes Detection Easier with Technology!

    Updated: 2012-09-19 19:25:32
    The Prostate Cancer Awareness Project (PCAP) is a non-profit charity group based in Manhattan Beach, CA. They work to create prostate cancer awareness events, free screening programs and the innovative “Visual Prostate Cancer Detection System.” A visual way for men to track their prostate and PSA levels over time. There are an estimated 30,000 American men [...] No related posts.

  • Taxane-Based Chemotherapy Drugs May Be Underestimated, Especially Against Advanced Prostate Cancer

    Updated: 2012-09-18 18:41:03
    According to researchers at Weill Cornell Medical College in the Sept. 15 issue of the journal Cancer Research, taxne-based chemotherapy drugs are not well understood as they may be more powerful than many have believed. Generally, it is believed that taxane chemotherapy (paclitaxel, docetaxel and cabazitaxel) just stop a cancer cell from dividing — but [...]

  • People admit risking their health by putting off visit to the GP

    Updated: 2012-09-18 00:01:00
    Almost one in three (32 per cent) people in the UK say that if they had an unusual or persistent change to their body, thinking it would go away in its own time would stop them from visiting their GP according to a new survey from Cancer Research UK.

  • Abiraterone Tx Boosts Survival in Prostate Cancer

    Updated: 2012-09-17 23:30:00
    Final results of a phase III trial confirm that treatment with abiraterone prolongs overall survival in advanced prostate cancer that has progressed after docetaxel therapy.

  • Call to Stop PSA Screening Has Some Effect

    Updated: 2012-09-17 21:32:18
    A small but significant number of older Medicare beneficiaries saw a decline in prostate-specific antigen (PSA)-based cancer screening after the U.S. Preventive Services Task Force (USPSTF) recommended against the screening in 2008, researchers said.

  • Norwegian court backs ban on tobacco displays

    Updated: 2012-09-17 17:34:00
    An Oslo court has backed the Norwegian government's right to introduce laws banning the visible display of tobacco products in stores.

  • More Information About C11 Choline Scans & Some of the Other Alternative Scans Used to ID Focal Advanced Prostate Cancer Recurrences

    Updated: 2012-09-16 14:36:30
    Off-line I have received a number of additional questions about the use of imaging with c11 choline (see my post at http://advancedprostatecancer.net/?p=3433). The questions ranged from what is c11 choline to how it compares to some of the other more sensitive PET scans contrasts that are being used to identify specific locations of recurrent advanced [...]

  • A Great Stride In PET Imaging, But Not A Panacea – C11 Choline For Diagnosing Recurrent Prostate Cancer

    Updated: 2012-09-14 19:07:20
    The FDA has approved c11 choline Injection, a Positron Emission Tomography (PET) imaging agent, for use in men to detect prostate cancer recurrences and to locate specific body sites for follow-up tissue sampling, testing and treatment. The indicated use for c11 choline injection is men with elevated prostate specific antigen (PSA) levels after earlier primary [...]

  • September is Prostate Cancer Awareness Month

    Updated: 2012-09-14 18:07:48
    Women Against Prostate Cancer helping women win the war against prostate cancer Home Donate Fundraising Ideas Join the 1-in-6 Club Today Resources Books Additional Resources Intimacy Resource Center Treatment Decision Guide Understanding Clinical Trials WAPC Family Tree Blog Take Action 2011 WAPC Advocacy Day Share Your Story Amy’s Story Anne’s Story Chris’s Story Debbie’s Story Pearl’s Story Sherry L’s Story Submit Your Prostate Cancer Story Share your video story More Stories of Inspiration Press Area About Us Board of Directors Steering Committee Chapters Contact Us WAPC Internships Shop You are here : Home Prostate Cancer Blog September is Prostate Cancer Awareness Month September is Prostate Cancer Awareness Month Filed in Prostate Cancer Blog on September 14, 2012 with no comments

  • Trio of studies outline 'genomic landscape' of non-small cell lung cancer

    Updated: 2012-09-14 15:54:00
    Researchers have painted the most detailed picture yet of the faulty genes involved in non-small cell lung cancer (NSCLC), one of the world's most hard-to-treat cancers.

  • Post-menopausal women with diabetes at greater risk of breast cancer

    Updated: 2012-09-14 00:01:00
    Women with type II diabetes are nearly 30 per cent more likely to get breast cancer, according to results of a comprehensive review published in the British Journal of Cancer today (Friday).

  • Loss of 'DNA tag' could be key to melanoma growth

    Updated: 2012-09-13 17:00:00
    Skin cells that have lost a common chemical tag from their DNA could be more likely to develop into melanoma cells - the most deadly type of skin cancer - according to US research.

  • No QoL Hit with Long-Term Finasteride

    Updated: 2012-09-13 05:00:00
    Long-term treatment with the 5 alpha-reductase inhibitor finasteride (Proscar, Propecia) did not adversely affect men's health-related quality of life, a new analysis of a large randomized trial showed.

  • FDA OKs PET Agent for Prostate Cancer

    Updated: 2012-09-12 21:33:01
    WASHINGTON -- The FDA has approved the positron emission tomography (PET) imaging agent Choline C 11 Injection for production and use in detecting recurrent prostate cancer.

  • Study highlights potential drug target for one in ten breast cancers

    Updated: 2012-09-11 16:00:00
    Cancer Research UK scientists have discovered how a key protein fuels breast cancer growth by boosting numbers of cancer stem cells in tumours that have low levels of a protein called claudin, accounting for up to 10 per cent of all breast cancers.

  • Genetic link to Barrett's oesophagus identified for first time

    Updated: 2012-09-10 16:47:00
    UK scientists have discovered the genetic basis for why some people are more at risk of developing Barrett's oesophagus, a condition that increases the risk of oesophageal cancer.

  • Discovery could lead to targeted treatment for small-cell lung cancer

    Updated: 2012-09-07 17:56:00
    US researchers have discovered two molecules inside cells that may be important in the development of small cell lung cancer (SCLC).

  • Astex Pharmaceuticals, Cancer Research Technology and The Institute of Cancer Research announce epigenetic drug discovery collaboration

    Updated: 2012-09-07 08:00:00
    Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, Cancer Research Technology Limited (CRT) and The Institute of Cancer Research, London, have initiated a collaboration to discover and develop drug candidates targeting an undisclosed epigenetic target in a blood cancer with high unmet medical need.

  • Exposure to X-rays raises risk of breast cancer in young women with BRCA faults

    Updated: 2012-09-06 23:30:00
    Women with faults in BRCA genes are more likely to develop breast cancer if they are exposed to chest X-rays before they are 30.

  • Existing drug could protect against sore mouth after radiotherapy

    Updated: 2012-09-06 18:07:00
    An existing drug, used to stop transplanted organs being rejected, could prevent a common side effect of radiotherapy for head and neck cancers, according to US research on mice.

  • Stop-start hormone therapy better than continual hormone therapy for prostate cancer

    Updated: 2012-09-06 00:01:00
    Men with prostate cancer who receive hormone therapy intermittently respond as well as those who receive it over a continuous time period, and enjoy quality-of-life benefits, according to a new Cancer Research UK-funded study* published in the New England Journal of Medicine today.

  • Cancer Research UK appoints new trustee

    Updated: 2012-09-06 00:01:00
    Cancer Research UK today (5 September 2012) announced the appointment of a new Member and Trustee, Professor Peter Selby, President of the Association of Cancer Physicians and Director of the Leeds Institute of Molecular Medicine.

  • On/Off Androgen Ablation Matches Nonstop Therapy

    Updated: 2012-09-05 22:00:00
    Intermittent androgen deprivation therapy proved to be as effective as continuous treatment and was associated with better quality of life in asymptomatic men who had rising PSA levels after definitive prostate cancer treatment, a large randomized trial showed.

  • Study uncovers simple way of predicting severe pain following breast cancer surgery

    Updated: 2012-09-05 00:00:00
    Women having surgery for breast cancer are up to three times more likely to have severe pain in the first week after surgery if they suffer from other painful conditions, such as arthritis, low back pain and migraine, according to a Cancer Research UK study published today (Wednesday) in the British Journal of Cancer.

  • An active lifestyle helps lower breast cancer risk

    Updated: 2012-09-04 09:45:00
    An active lifestyle such as doing housework, brisk walking and gardening helps to reduce the chance of getting breast cancer, new research shows today.

Current Feed Items | Previous Months Items

Aug 2012 | Jul 2012 | Jun 2012 | May 2012 | Apr 2012 | Mar 2012